Labcorp Quarterly Cash Flow Statement
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Labcorp free cash flow
In the quarter ended Jun 30, 2026, Labcorp generated $445.5 million of operating cash flow and spent $131.6 million on capital expenditures. That left free cash flow of $313.9 million, a free-cash-flow margin of 8.4% of revenue. Free cash flow was down 42.2% from the prior year's $542.7 million.
Labcorp returned $412.5 million to shareholders: $58.7 million in dividends and $353.8 million in share repurchases, equal to 131% of free cash flow. Free cash flow covered dividend payments 5.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Labcorp cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 299.10M | 278.00M | 164.90M | 261.50M | 238.30M | 213.00M | 143.60M | 169.60M | 205.60M | 228.30M | -166.80M | 183.60M |
| Net Income growth (YoY) | +25.51% | +30.52% | +14.83% | +54.19% | +15.90% | -6.70% | — | -7.63% | +8.73% | +7.03% | -318.32% | -48.02% |
| Depreciation & Amortization | 179.00M | 173.30M | 173.00M | 171.00M | 170.30M | 166.80M | 170.60M | 161.50M | 156.90M | 154.50M | 146.40M | 145.90M |
| Stock-Based Compensation | 34.90M | 31.70M | 29.70M | 29.20M | 34.10M | 32.80M | 27.30M | 27.00M | 30.80M | 31.60M | 27.00M | 34.40M |
| Change in Working Capital | -130.50M | -319.30M | 150.40M | -174.60M | 99.00M | -273.90M | 275.20M | -121.70M | 149.90M | -375.30M | 309.50M | -97.30M |
| Operating Cash Flow | 445.50M | 191.50M | 614.20M | 387.20M | 620.60M | 18.50M | 777.20M | 277.30M | 561.10M | -29.80M | 579.60M | 275.50M |
| Capital Expenditures | -131.60M | -121.00M | -123.90M | -106.70M | -77.90M | -126.00M | -112.10M | -115.80M | -128.20M | -133.80M | -167.20M | -104.90M |
| Investing Cash Flow | -366.20M | -322.10M | -389.90M | -374.00M | -94.10M | -336.00M | -209.60M | -579.10M | -185.00M | -393.10M | -330.60M | -487.60M |
| Dividends Paid | -58.70M | -61.20M | -59.30M | -59.90M | -59.90M | -61.60M | -60.10M | -60.50M | -60.40M | -62.10M | -61.10M | -63.90M |
| Share Repurchases | -353.80M | -98.00M | -225.00M | -25.00M | -200.00M | 0 | -75.10M | -75.00M | — | — | 9.00M | -1.01B |
| Debt Issued | — | — | 0 | — | — | — | 0 | — | — | — | 0 | — |
| Debt Repaid | -500.00M | 0 | 0 | 0 | 0 | -1.00B | -400.00M | -600.00M | 0 | 0 | -300.00M | — |
| Financing Cash Flow | -919.90M | 580.50M | -290.40M | -59.50M | -267.40M | -839.70M | -546.70M | 1.55B | -210.00M | -11.70M | -446.50M | -1.10B |
| Net Change in Cash | -839.30M | 448.80M | -65.80M | -49.20M | 277.90M | -1.15B | 1.40M | 1.25B | 165.80M | -437.50M | -191.10M | -1.31B |
| Free Cash Flow | 313.90M | 70.50M | 490.30M | 280.50M | 542.70M | -107.50M | 665.10M | 161.50M | 432.90M | -163.60M | 412.40M | 170.60M |
This table shows 12 quarterly periods of Labcorp's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LH's reporting calendar. What is a cash flow statement?